More recently, Zhao et al. have shown in different animal models that in the context of obesity and leptin resistance, a partial leptin reduction after intraperitoneal (IP) treatment with anti-leptin antibodies reduced significantly liver steatosis probably due to an increase in leptin sensitivity in the hypothalamus [75]. The gene discussed is LEP; the disease is obesity disorder.